Avid Bioservices Q2 EPS $(0.27) Misses $(0.12) Estimate, Sales $33.50M Miss $33.80M Estimate
Avid Bioservices Q2 EPS $(0.27) Misses $(0.12) Estimate, Sales $33.50M Miss $33.80M Estimate
Avid Bioservices 第二季度每股收益$(0.27) 未達到$(0.12)的預期，銷售額3350萬未達到3380萬的預期。
Avid Bioservices (NASDAQ:CDMO) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.12) by 125 percent. This is a 80 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $33.50 million which missed the analyst consensus estimate of $33.80 million by 0.89 percent. This is a 31.89 percent increase over sales of $25.40 million the same period last year.